Air T is a holding company. Through its subsidiaries, the company operates the following industry segments: overnight air cargo, which operates in the air express delivery services industry; ground equipment sales, which manufactures and provides mobile deicers and other equipment products; ground support services, which provides ground support equipment maintenance and facilities maintenance services; commercial aircraft, engines and parts, which provides services including commercial aircraft disassembly/part-out services; and printing equipment and maintenance, which designs, manufactures and sells digital print production equipment and provides maintenance services to commercial customers.

American Assets Trust is a self-administered real estate investment trust that owns, operates, acquires and develops retail, office, multifamily and mixed-use properties in Southern California, Northern California, Oregon, Washington, Texas and Hawaii. The company operates in four segments: Retail, which primarily include rental of retail space and other tenant services, including tenant reimbursements, parking and storage space rental; Office, which primarily include rental of office space and other tenant services; Multifamily, which include rental of apartments and other tenant services; and Mixed-use, which include rental of retail space and other tenant services.

Ares Capital is a finance company that is a closed-end management investment company. The company's investment objective is to generate both current income and capital appreciation through debt and equity investments. The company invests primarily in United States middle-market companies. The company invests primarily in first lien senior secured loans (including unitranche loans, which are loans that combine both senior and mezzanine debt, generally in a first lien position), second lien senior secured loans and mezzanine debt, which in some cases includes an equity component. To a lesser extent, the company also make preferred and/or common equity investments.

Cara Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities with a primary focus on pruritus as well as pain by selectively targeting peripheral kappa opioid receptors. The company is developing a proprietary class of product candidates, led by KORSUVA (CR845/difelikefalin), a kappa opioid receptor agonist that targets the body's peripheral nervous system, as well as certain immune cells. The company's primary product candidate, CR845/difelikefalin, is a chemical entity, which is designed to selectively stimulate kappa, rather than mu, and delta opioid receptors outside of the CNS.

Comstock Resources is an independent energy company engaged in the acquisition, exploration, development and production of oil and natural gas. The company's oil and gas operations are primarily concentrated in Louisiana, Texas and North Dakota. The company also has operations in other regions, primarily in New Mexico and the Mid-Continent region.

First Financial Bankshares is a financial holding company. Through its subsidiaries, the company conducts commercial banking business. The company's banking centers are located primarily in Central, North Central, Southeast and West Texas. Each of the company's bank regions provides general commercial banking services, which include accepting and holding checking, savings and time deposits, making loans, automated teller machines, drive-in and night deposit services, safe deposit facilities, remote deposit capture, internet banking, mobile banking, payroll cards, transmitting funds, and performing other customary commercial banking services.

Innovative Solutions and Support is a systems integrator that designs, develops, manufactures, sells, and services air data equipment, engine display systems, standby equipment, primary flight guidance, autothrottles and cockpit display systems for retrofit applications and original equipment manufacturers (OEMs). The company supplies Flight Management Systems, Flat Panel Display Systems, Autothrottle Systems, air data equipment, Integrated Standby Units and Global Positioning System receivers that enable reduced carbon footprint navigation. The company sells to both the OEM and the retrofit markets.

Medpace Holdings is a holding company. Through its subsidiaries, the company is a clinical contract research organization focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The company provides a range of services supporting the clinical development process from Phase I to Phase IV. The company provides these services across a range of therapeutic areas. The company's line of clinical development services includes, but is not limited to, study start-up, patient recruitment and retention, clinical monitoring, risk-based monitoring, medical writing, data management, pharmacovigilance, and molecular and genetic testing.

Old National Bancorp is a financial holding company that operates primarily in Indiana, Kentucky, Michigan, Wisconsin, and Minnesota. Through its wholly owned banking subsidiary, Old National Bank, the company provides a range of services, including commercial and consumer loan and depository services, private banking, brokerage, trust, investment advisory, and other banking services. In addition to the community banking services of lending and providing deposit services, the company provides wealth management, investment, and foreign currency services. For businesses, the company provides treasury management, merchant, health savings, and capital markets services, among others.

Opko Health is a healthcare company. The company manages two segments: Diagnostics, which provides laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional healthcare; and Pharmaceutical, which includes Rayaldee for the treatment of secondary hyperparathyroidism in adults with chronic kidney disease (CKD) and vitamin D insufficiency, and Alpharen (Fermagate Tablets) for the treatment of hyperphosphatemia in CKD patients requiring regular hemodialysis.

Spok Holdings provides a suite of unified clinical communication and collaboration solutions that include call center operations, clinical alerting and notifications, one-way and two-way wireless messaging services, mobile communications and public safety solutions. The company also develops, sells and supports enterprise-wide systems for hospitals and other organizations needing to automate, centralize and standardize mission clinical communications. These solutions are used for contact centers, clinical alerting and notification, mobile communications and messaging and for public safety notifications.

Starbucks is a roaster, marketer and retailer of coffee. The company's segments are: Americas, which is inclusive of the United States, Canada, and Latin America; International, which is inclusive of China, Japan, Asia Pacific, Europe, Middle East, and Africa; and Channel Development. The company's Americas and International segments include both company-operated and licensed stores. The company's Channel Development segment includes roasted whole bean and ground coffees, Seattle's Best Coffee?, Starbucks- and Teavana-branded single-serve products, a variety of ready-to-drink beverages, and other products sold worldwide outside of the company's company-operated and licensed stores.

Veritone is a provider of artificial intelligence (AI) computing solutions. The company has developed aiWARE?, a proprietary AI operating system that integrates and orchestrates an open ecosystem of performing cognitive engines. The company'saiWARE platform incorporates proprietary technology to integrate and intelligently orchestrate a variety of cognitive engine capabilities to mimic human cognitive functions. The company also operates a full service media advertising agency. The company's services include media planning and strategy, advertisement buying and placement, campaign messaging, clearance verification and attribution, and custom analytics.

XOMA is a biotech royalty aggregator with a portfolio of pre-commercial therapeutic candidates. The company's monoclonal antibodies and technologies product candidates are: IL-2, which targets Interleukin 2 as a therapy for metastatic melanoma and renal cell carcinoma; PTH1R, an anti-parathyroid receptor pipeline that includes several functional antibody antagonists targeting PTH1R, a G-protein-coupled receptor involved in the regulation of calcium metabolism; XMetA, an insulin receptor-activating antibody designed to provide long-acting reduction of hyperglycemia in Type 2 diabetic patients; X213, an allosteric inhibitor of prolactin action.